Biotech Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM August 30, 2026
Biotech HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China August 30, 2026
Financial LexinFintech Holdings Ltd. Reports Second Quarter 2026 Unaudited Financial Results August 30, 2026
Biotech Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 August 29, 2026
Health Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 August 29, 2026
Financial Matador Technologies Receives TSX Venture Exchange Conditional Approval for Proposed Creation of a New Class of Preferred Shares August 28, 2026